Over the past year, we’ve learned about how Ozempic (and other GLP-1 medications) can impact you brain, your face, your sex ...
AS GLP-1 AGONISTS soar in popularity—about 12 percent of the U.S. population has tried one, most often Ozempic or Wegovy ...
Danish health authorities said on Monday they would ask the European Union's drug regulator to review the findings of two ...
The Danish Medicines Agency said it would ask European authorities to review two new studies that point to a link between ...
The Danish Medicines Agency said it would ask European authorities to review two new studies that point to a link between ...
Novo Nordisk’s takeover of Catalent and the Danish firm’s push to launch a new generation of drugs could boost the importance ...
Some people are not taking weight-loss medications responsibly, the physician says, and don't realize their full implications ...
He cited a study that found that although the U.S. has the costliest healthcare system in the world, it ranks 42nd in life ...
Jelly Roll looked back on his relationship with food before his recent dramatic weight loss. He says he dropped the weight ...
Two independent studies from the University of Southern Denmark (SDU) show that patients with type 2 diabetes who are treated with the drug Ozempic have an increased risk of developing damage to the ...
Part of the joy of the season may be gone — or feel different — for people who are taking popular weight-loss drugs and can't ...
Novo Nordisk unveils a $1.2 billion production facility in Denmark and finalizes Catalent acquisition, with financial and ...